Eli Lilly Reports Pre-Launch Inventories Capitalized As Of March 31, 2025 $601.4 Million, Primarily Related To Orforglipron - Filing
May 1 (Reuters) - Eli Lilly and Co LLY.N:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.